Author: Kirk Jackisch
This case study outlines how to implement value pricing approaches in the difficult process of pricing a new pharmaceutical product. The process implemented in this project enabled the client to achieve market access in the US and the EU5 (Germany, France, UK, Italy, Spain) for a first-in-class, ultra-orphan oncology therapy. Though specific to the pharmaceutical industry, this case study presents new product pricing strategies that can be implemented by pricers in multiple industries. Kirk Jackisch is the President of Iris Pricing Solutions. He can be reached at kjackisch@pricingsolutions.com.
The Pricing Advisor, December 2020
In the pharmaceutical industry, …Read More